ALEXIS KEESTER: Open Payments
NPI 1629650494 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 53 payments from 15 companies in 2025. Trend: 2023 $101 · 2024 $1,048 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $208 |
| ABBVIE INC. | 13 | $196 |
| Corcept Therapeutics | 8 | $148 |
| PFIZER INC. | 6 | $106 |
| Lilly USA, LLC | 5 | $106 |
| Novo Nordisk Inc | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Intra-Sana Laboratories | 2 | $38 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: TRINTELLIX, Korlym, UBRELVY, NURTEC ODT, MOUNJARO, VRAYLAR, ZEPBOUND, Wegovy.
Industry payments across OK — which companies pay providers there.
